Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells

Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells

The present study investigated the impact of carnosic acid (CA) from rosemary on the levodopa (L-dopa)-induced dyskinesia (LID) in rats treated with 6-hydroxydopamine (6-OHDA). To establish the model of LID, 6-OHDA-lesioned rats were injected intraperitoneally with 30 mg/kg L-dopa once a day for 36 ...

Full description

Bibliographic Details
Main Authors:	Chun-Yi Lai, Chia-Yuan Lin, Chi-Rei Wu, Chon-Haw Tsai, Chia-Wen Tsai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Pharmacology
Subjects:	carnosic acid 6-hydroxydopamine levodopa-induced dyskinesia DARPP-32/ΔFosB ERK1/2-c-jun
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.703894/full

Similar Items

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats
by: Xuebing Cao, et al.

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats
by: Eleonora Maries, et al.
Published: (2006-01-01)

Effects of pulsatile l-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)
by: N Stefanova, et al.
Published: (2004-04-01)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
by: Eugene Huh, et al.
Published: (2019-01-01)

The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias
by: Wei-Li Kuan, et al.
Published: (2007-03-01)

Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s disease
by: Yunmin Ding, et al.
Published: (2007-07-01)

Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model
by: Laure Chagniel, et al.
Published: (2012-01-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function
by: Christian Winkler, et al.
Published: (2002-07-01)

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01)

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
by: Wu N, et al.
Published: (2018-07-01)

The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias
by: Vishakh Iyer, et al.
Published: (2021-11-01)

Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice
by: Mokarian Faezeh, et al.
Published: (2018-12-01)

Less Pulsatile Levodopa Therapy (6 Doses Daily) Is Associated with a Reduced Incidence of Dyskinesia
by: Mark M. Lin, et al.
Published: (2019-01-01)

Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats
by: Alberto Brugnoli, et al.
Published: (2020-10-01)

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats
by: Edward J. R. Fletcher, et al.
Published: (2020-09-01)

Levodopa-induced belly dancer's dyskinesia: Case report
by: José Renan Miranda Cavalcante-Filho, et al.
Published: (2020-01-01)

MALADAPTIVE PLASTICITY IN LEVODOPA-INDUCED DYSKINESIAS AND TARDIVE DYSKINESIAS: OLD AND NEW INSIGHTS ON THE EFFECTS OF DOPAMINE RECEPTOR PHARMACOLOGY
by: Antonio eCerasa, et al.
Published: (2014-04-01)

Treatment of Levodopa-induced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
by: Amir Hassan Habibi, et al.
Published: (2018-10-01)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
by: Tianbin Song, et al.
Published: (2021-03-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
by: A.A. Martinez, et al.
Published: (2015-02-01)

Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
by: Michael H. Li, et al.
Published: (2018-11-01)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
by: Sharma VD, et al.
Published: (2018-04-01)

Future Scenarios for Levodopa-induced Dyskinesias in Parkinson’s disease
by: Antonio eCerasa, et al.
Published: (2015-04-01)

Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
by: Mario Gustavo Murer, et al.
Published: (2011-08-01)

Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa–Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson’s Rats
by: Wen-Wen Wang, et al.
Published: (2019-06-01)

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes
by: Luca Pagliaroli, et al.
Published: (2021-06-01)

Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia
by: Tatsuya Ueno, et al.
Published: (2014-04-01)

Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia
by: Alberto Brugnoli, et al.
Published: (2016-01-01)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
by: Changwei Yang, et al.
Published: (2020-03-01)

Experimental study on the relationship between levodopa ⁃induced dyskinesia and phosphorylation of ERK in the striatum
by: Lu SONG, et al.
Published: (2011-02-01)

Consensus paper: Use of transcranial magnetic stimulation to probe motor cortex plasticity in dystonia and levodopa-induced dyskinesia
by: Angelo Quartarone, MD, et al.
Published: (2009-04-01)

Efficacy of subthalamic deep brain stimulation for levodopa-induced dyskinesia in patients with Parkinson's disease: retrospective analysis of 12 cases
by: WANG Kuan, et al.
Published: (2020-12-01)

Cytoplasmic Polyadenylation Element Binding Proteins CPEB1 and CPEB3 Regulate the Translation of FosB and Are Required for Maintaining Addiction-Like Behaviors Induced by Cocaine
by: Bettina Drisaldi, et al.
Published: (2020-07-01)

Angiotensin AT1 and AT2 receptor heteromer expression in the hemilesioned rat model of Parkinson’s disease that increases with levodopa-induced dyskinesia
by: Rafael Rivas-Santisteban, et al.
Published: (2020-08-01)

The blood–brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates—Evidence from in vivo neuroimaging studies
by: Arnar Astradsson, et al.
Published: (2009-09-01)

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats
by: Kerstin Buck, et al.
Published: (2008-02-01)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
by: Hesna Bektaş, et al.
Published: (2014-04-01)

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease
by: Debleena Guin, et al.
Published: (2017-09-01)

Cannot write session to /tmp/vufind_sessions/sess_7nc7bmefr73kh1vcop1u2ruo9b